EXMED
ActiveSummary
EXMED has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €348k and a net result of €33k. Equity remains stable across the filed fiscal years (±2.3% per year). Its solvency ranks better than 58% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
84
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability77▲+8
Solvency96▼-4
Growth52=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 2.56 against 5.61 in 2024; short-term debt: 28.2% and cash: 14.5% of total assets), and 28.6% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
71.4%
Return on assets
6.8%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
27 d late
2024
29 d late
2023
47 d early
2022
29 d late
2021
31 d early
2020
1 d early
2019
54 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€348k▼ 2.9%
2024 · €359k
2018: €288k
2019: €322k
2020: €344k
2021: €375k
2022: €401k
2023: €358k
2024: €359k
2018 → 2025
Total assets
€488k▲ 19.6%
2024 · €408k
2018: €415k
2019: €434k
2020: €434k
2021: €440k
2022: €466k
2023: €397k
2024: €408k
2018 → 2025
Net result
€33k▲ 3,330%
2024 · €971
2018: €40k
2019: €34k
2020: €22k
2021: €30k
2022: €27k
2023: €20k
2024: €971
2018 → 2025
Working capital
€214k▼ 1.8%
2024 · €218k
2018: €207k
2019: €229k
2020: €235k
2021: €250k
2022: €260k
2023: €219k
2024: €218k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€375k-€401k▲ 7.1%€358k▼ 10.8%€359k▲ 0.3%€348k▼ 2.9%
Operating result€47k-€41k▼ 12.4%€30k▼ 27.5%€3k▼ 89.7%€48k▲ 1,461%
Net result€30k-€27k▼ 11.9%€20k▼ 25.5%€971▼ 95.1%€33k▲ 3,330%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 1,461% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €488k
Fixed assets
€136k ▼ 4.4%
Current assets
€352k ▲ 32.5%
Equity and liabilities €488k
Equity
€348k ▼ 2.9%
Debt
€139k ▲ 185%
Debt's share of the balance-sheet total rises from 12.0% to 28.6%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€58k▲
2024 · €12k
Cash flow
€43k▲
2024 · €10k
Current ratio
2.56▼
2024 · 5.61
Debt to equity
0.40▲
2024 · 0.14
ROE
9.6%▲
2024 · 0.3%
ROA
6.8%▲
2024 · 0.2%
Interest coverage
51.10▲
2024 · 19.57
Debt ≤ 1 year
€137k▲
2024 · €47k
Income taxes
€14k▲
2024 · €2k
Staff costs
€135k▲
2024 · €113k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 49 lines
Balance sheet
Code20242025
Assets
Total assets20/58€408k€488k▲
Fixed assets21/28€142k€136k▼
Intangible fixed assets21€0€0=
Tangible fixed assets22/27€142k€136k▼
Land and buildings22€128k€121k▼
Plant, machinery and equipment23€10k€9k▼
Furniture and vehicles24€4k€5k▲
Current assets29/58€266k€352k▲
Amounts receivable within one year40/41€88k€185k▲
Trade receivables40€68k€165k▲
Other amounts receivable41€20k€20k▼
Current investments50/53€95k€95k=
Cash at bank and in hand54/58€79k€71k▼
Deferred charges and accrued income490/1€4k€545▼
Equity and liabilities
Total equity and liabilities10/49€408k€488k▲
Equity10/15€359k€348k▼
Contributions10/11€6k€6k=
Reserves13€233k€223k▼
Distributable reserves133€233k€223k▼
Profit (loss) carried forward14€119k€119k=
Amounts payable17/49€49k€139k▲
Amounts payable within one year42/48€47k€137k▲
Trade debts44€22k€35k▲
Suppliers440/4€22k€35k▲
Taxes, remuneration and social security45€25k€71k▲
Taxes450/3€6k€38k▲
Remuneration and social security454/9€20k€32k▲
Other amounts payable47/48€77€32k▲
Accrued charges and deferred income492/3€2k€2k▲
Income statement
Code20242025
Remuneration, social security and pensions62€113k€135k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€10k▲
Other operating charges640/8€3k€3k▼
Gross operating margin9900€128k€196k▲
Operating profit (loss)9901€3k€48k▲
Financial income75/76B€202€351▲
Recurring financial income75€202€351▲
Financial charges65/66B€609€1k▲
Recurring financial charges65€609€1k▲
Profit (loss) for the period before taxes9903€3k€47k▲
Income taxes67/77€2k€14k▲
Profit (loss) for the period9904€971€33k▲
Profit (loss) for the period to be appropriated9905€971€33k▲
Appropriation of the result
Profit (loss) to be appropriated9906€120k€153k▲
Profit (loss) brought forward from the previous period14P€119k€119k=
Transfer from equity791/2-€44k
Transfer to equity691/2€971€33k▲
To other reserves6921€971€33k▲
Profit to be distributed694/7-€44k
Return on contributions (dividend)694-€44k
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
31-12
Financial
Weakest financial yearnet €971 ▼95.1%
Net result drops to €971, the lowest in the series; recovery starts the following year.
14-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
23-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 54 days late
2019
29-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 29 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Charleroi · 1 establishment unit since 1990
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de Nalinnes 2666001 CharleroiGround area
4,998 m²
Parcel 52392C0753/00K031, Wallonia. Linked by address, not a title deed.
1 establishment unit
EXMED
since 19902.231.313.368
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52392C0753/00K031 | Wallonia | 4,998 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
6488J1T6QE761BO97C75
Similar companies · same sector, comparable size
CABINET D'ANESTHESIE MIEKE VANHOONACKER
BE 0842.281.583
Mettet · Eq €348,625
RD ANESTH
BE 0791.283.339
Ham-sur-Heure-Nalinnes · Eq €347,945
DOCNIC
BE 0755.563.088
Rotselaar · Eq €347,693
Drs Vandeputte-Vande Casteele
BE 0878.408.244
Bonheiden · Eq €348,884
CORYSANIC
BE 0462.964.964
Mons · Eq €347,681
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,628 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-04-1990
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 36 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:071312173